Reversal of left ventricular hypertrophy with different classes of drugs causes differing ventricular biochemical changes.
Arita
M
M
Alton Ochsner Medical Foundation, New Orleans, Lousiana 70121.
Horinaka
S
S
Komatsu
K
K
Frohlich
E D
ED
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology; D000818:Animals; D000959:Antihypertensive Agents / Q000145:classification / Q000494:pharmacology*; D001552:Benzazepines / Q000494:pharmacology; D017272:Celiprolol / Q000494:pharmacology; D003094:Collagen / Q000378:metabolism; D006973:Hypertension / Q000150:complications / Q000188:drug therapy; D017379:Hypertrophy, Left Ventricular / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism; D008297:Male; D011506:Proteins / Q000378:metabolism; D012313:RNA / Q000378:metabolism; D051381:Rats; D011918:Rats, Inbred SHR; D011921:Rats, Inbred WKY; D014700:Verapamil / Q000494:pharmacology
D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D001552:Benzazepines; D011506:Proteins; D012313:RNA; D003094:Collagen; D014700:Verapamil; D017272:Celiprolol; C044946:benazepril